Fibrinolytic Enzyme - An Overview

Area of Science:

• Biochemistry
• Pharmacology
• Cardiology

Background:

• Cardiovascular diseases (CVDs) are leading global causes of mortality, encompassing conditions like heart attack, stroke, and hypertension.
• Current CVD treatments such as surgery and medications have limitations and adverse effects.
• Fibrinolytic agents, which degrade fibrin, offer a potential therapeutic avenue for CVDs.

Purpose of the Study:

• To review fibrinolytic enzymes, their mechanisms of action, and their diverse natural sources.
• To evaluate the therapeutic potential of these enzymes in treating cardiovascular diseases.
• To highlight fibrinolytic enzymes as promising alternatives to conventional CVD treatments.

Main Methods:

• Literature review of scientific databases focusing on fibrinolytic enzymes and cardiovascular diseases.
• Analysis of biochemical mechanisms by which fibrinolytic enzymes degrade fibrin.
• Compilation of information on the various biological sources of fibrinolytic enzymes.

Main Results:

• Fibrinolytic enzymes, including streptokinase, nattokinase, and urokinase, are derived from bacteria, fungi, plants, and other organisms.
• These enzymes exhibit diverse mechanisms for fibrin degradation.
• Various fibrinolytic enzymes show significant therapeutic potential for cardiovascular conditions.

Conclusions:

• Fibrinolytic enzymes represent a promising class of therapeutic agents for cardiovascular diseases.
• Their natural origins and enzymatic mechanisms offer potential advantages over existing treatments.
• Further research into fibrinolytic enzymes could lead to novel strategies for managing CVDs.